A. Sardella

发表

Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.

D. Altavilla, F. Squadrito, A. Caputi, 1994, Pharmacological research.

Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock.

L. Minutoli, D. Altavilla, F. Squadrito, 2002, Cardiovascular research.

Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse.

D. Cucinotta, G. Russo, D. Altavilla, 2001, Diabetes.

Inhibition of tumour necrosis factor and reversal of endotoxin‐induced shock by U‐83836E, a ‘second generation’ lazaroid in rats

D. Altavilla, F. Squadrito, G. Campo, 1998, British journal of pharmacology.

G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.

D. Altavilla, F. Squadrito, G. Campo, 1995, European journal of pharmacology.

Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock

D. Altavilla, F. Squadrito, A. Alonci, 1996, Inflammation Research.

Protective effects of Cyclosporin‐A in splanchnic artery occlusion shock

L. Minutoli, D. Altavilla, F. Squadrito, 2000, British journal of pharmacology.

Effect of sulfatide on acute lung injury during endotoxemia in rats.

L. Minutoli, D. Altavilla, F. Squadrito, 1999, Life sciences.

The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.

D. Altavilla, F. Squadrito, G. Campo, 1999, European journal of pharmacology.

Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.

D. Altavilla, F. Squadrito, A. Sardella, 2005, Clinical science.

TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock

D. Altavilla, F. Squadrito, G. Campo, 1994, Agents and Actions.

The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556.

L. Minutoli, D. Altavilla, F. Squadrito, 2000, Life sciences.

Protective Effects of G 619, a Dual Thromboxane Synthase Inhibitor and Thromboxane A2 Receptor Antagonist, in Splanchnic Artery Occlusion Shock

D. Altavilla, F. Squadrito, G. Campo, 1992, Journal of cardiovascular pharmacology.

Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats.

D. Cucinotta, D. Altavilla, F. Squadrito, 1993, European journal of pharmacology.

Inhibition of nuclear factor-κB activation by IRFI 042, protects against endotoxin-induced shock

L. Minutoli, D. Altavilla, F. Squadrito, 2002 .

Protective Effects of L‐659,989, a Platelet‐Activating Factor Receptor Antagonist, in Myocardial Ischemia and Reperfusion in Rats

D. Altavilla, F. Squadrito, G. Campo, 1994, Journal of cardiovascular pharmacology.